Generic Name and Formulations:
Meclizine HCl 12.5mg, 25mg; tabs.
Various generic manufacturers
Indications for Meclizine:
Motion sickness prophylaxis. Vertigo of vestibular origin.
Motion sickness: 25–50mg 1 hour prior to departure, repeated every 24 hours as needed. Vertigo: 25–100mg/day in divided doses.
Asthma. Glaucoma. GI or GU obstruction. Hepatic or renal impairment. Elderly. Pregnancy (Cat.B). Nursing mothers.
Alcohol, tranquilizers, sedative-hypnotics potentiate CNS depression. May be potentiated by CYP2D6 inhibitors.
Drowsiness, sedation, dry mouth, blurred vision.
Formerly known under the brand name Antivert.
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics